Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,917-20,928 of 23,847
Drug study icon
CompletedNCT00553319

Adderall-XR for Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

This study exists to compare options and see whether the medication Adderall-XR offers something meaningfully different. Researchers are trying to understand whether the medication Adderall-XR can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Minneapolis
ADHDDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Drug study icon
CompletedNCT05365295

ADHD Children's Sensitivity to Memory Error Production

This study exists to compare options and see whether the medication ADHD offers something meaningfully different. Researchers are trying to understand whether the medication ADHD can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Angers
ADHDOtherFrom 8 Years to 11 Years
Countries
France
Sponsor
University Hospital, Angers
Condition
ADHD
Behavioral study icon
CompletedNCT05268965

Affective Forecasting Skills in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Lille
PTSDBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Lille
Condition
PTSD
Drug study icon
CompletedNCT06056414

Anxiety After a Session of Energy Resonance by Cutaneous Stimulation

This study exists to explore whether the medication Anxiety could improve care and understanding. Researchers are trying to understand whether the medication Anxiety can better support energy, concentration, and everyday functioning.

In Rouen
AnxietyOtherOver 18 Years
Countries
France
Sponsor
Centre Henri Becquerel
Condition
Anxiety
Drug study icon
CompletedNCT00221962

Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Aripiprazole can improve attention, thinking, or day-to-day functioning.

In Cleveland
ADHDDrugFrom 8 Years to 12 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
ADHD
Drug study icon
CompletedNCT00194077

Aripiprazole (Abilify) in Children With Symptoms of Mania

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication Aripiprazole can improve attention, thinking, or day-to-day functioning.

In Cleveland
BipolarityDrugFrom 4 Years to 9 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT00194012

Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolarity

This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Aripiprazole in practice and what may need to be adjusted.

In Cleveland
BipolarityDrugFrom 5 Years to 17 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT00036348

Aripiprazole in people with a History of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.